Neuphoria Therapeutics NEUP
NASDAQ NEUP
$2.71 +0.02 (+0.74%)
At close: Nov 11, 2026 · 4:00 PM EST

Neuphoria Therapeutics (NEUP) EV to FCF (2025)

Updated

Neuphoria Therapeutics' EV to FCF came in at 2050.01 for fiscal Q1 2026 (quarter ended Sep 30, 2025), down 81.8% from the prior quarter.

Analysis

Neuphoria Therapeutics (NEUP) EV to FCF (2025) Analysis & Trends

Over the trailing twelve months to Sep 30, 2025, Neuphoria Therapeutics reported EV to FCF of 1999.89; for FY2025 (ended Jun 30, 2025), it was 11205.71.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Neuphoria Therapeutics 335.34 Mn 260.15 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 1,075.97
API Access

Neuphoria Therapeutics EV to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=NEUP&period=max&api_key=YOUR_API_KEY